Document and Entity Information
Document and Entity Information | Feb. 28, 2024 |
Cover [Abstract] | |
Amendment Flag | false |
Entity Central Index Key | 0001593899 |
Document Type | 8-K |
Document Period End Date | Feb. 28, 2024 |
Entity Registrant Name | Atea Pharmaceuticals, Inc. |
Entity Incorporation State Country Code | DE |
Entity File Number | 001-39661 |
Entity Tax Identification Number | 46-0574869 |
Entity Address, Address Line One | 225 Franklin Street |
Entity Address, Address Line Two | Suite 2100 |
Entity Address, City or Town | Boston |
Entity Address, State or Province | MA |
Entity Address, Postal Zip Code | 02110 |
City Area Code | (857) |
Local Phone Number | 284-8891 |
Written Communications | false |
Soliciting Material | false |
Pre Commencement Tender Offer | false |
Pre Commencement Issuer Tender Offer | false |
Security 12b Title | Common Stock, $0.001 par value per share |
Trading Symbol | AVIR |
Security Exchange Name | NASDAQ |
Entity Emerging Growth Company | false |